Qiagen Working With Moelis, Goldman Sachs on Review, CEO Says

Qiagen NV Chief Executive Officer Thierry Bernard said the European molecular testing firm is working with Moelis & Co. and Goldman Sachs Group Inc. to review strategic alternatives.

“We are not only ready and open to engage but we are doing this with the help of advisers,” Bernard said Monday in a presentation at the TD Cowen 46th Annual Health Care Conference in Boston.

Qiagen, which provides technologies and services for testing genetic materials, has attracted takeover interest multiple times in recent years, though the discussions never led to a deal. The company is committed to doing what is in ...